Back
to sessions
Oct 01
Quick Pitch
QP 24 - Radiation and Cancer Biology 7: Tumor Immune Interactions
Credits
| AMA PRA Category 1 Credits: | 1.00 |
Presentations
-
10:30am - 11:30am PT
Radiation and Cancer Biology 7: Tumor Immune Interactions
Speaker: Gregory Gan, MD, PhD - KUMC, Kansas city -
10:35am - 10:40am PT
ADAR1 Expression in CD8<sup>+</sup> T Cells Modulates Radiotherapy Response and Prognosis in Non-Small Cell Lung Cancer via Disrupting Mitochondrial Function
Speaker: Chen Tian, PhD - Shandong Cancer Hospital and Institute, Shandong First Medical University, Jinan -
10:40am - 10:45am PT
Tumor Immune Microenvironment Modulation by Single-Fraction vs. Multifraction SBRT in an Orthotopic NSCLC Mouse Model
Speaker: Lea Bouchard, MD, MS - University of Sherbrooke, Sherbrooke -
10:45am - 10:50am PT
hnRNPA1 Impedes the Anti-Tumor Immune Response Effect via Competitively Inhibiting TRIM21-Mediated Ubiquitination and Degradation of CD155
Speaker: Lu Zhang, MS, none - Chongqing University Cancer Hospital, Shapingba -
10:50am - 10:55am PT
Conventional Fractionated Elective Nodal Irradiation Preserves Early Antitumor Immunity and Efficacy Compared to Hypofractionated Protocols
Speaker: Genki Sato, MD - Kyoto University Hospital, Kyoto -
10:55am - 11:00am PT
Focal Adhesion Kinase Targeting Enhances Anti-Tumor Immunity Following Conventionally Fractionated Radiation
Speaker: Brian Leibowitz, PhD - University of Pittsburgh School of Medicine, Pittsburgh -
11:00am - 11:05am PT
Quantifying pan-cancer immune temperature to predict patient-specific radiation response and outcome
Speaker: Awino Maureiq Ojwang', PhD - MD Anderson Cancer Center, Houston